Acumen Pharmaceuticals (ABOS) Market Capitalization (2021 - 2026)

Acumen Pharmaceuticals has disclosed Market Capitalization across 6 years of filings, most recently posting $193.1 million for Q2 2026.

• In Q2 2026, Market Capitalization rose 174.79% year-over-year to $193.1 million; the TTM figure through Jun 2026 stood at $193.1 million (up 174.79% YoY), while the FY2025 annual figure was $127.8 million, up 23.66% from the prior year.
• Market Capitalization came in at $193.1 million for Q2 2026 at Acumen Pharmaceuticals, up from $170.5 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $406.2 million in Q3 2022 to a low of $66.6 million in Q1 2025.
• Average Market Capitalization over 5 years is $176.4 million, with a median of $168.5 million recorded in 2023.
• Year-over-year, Market Capitalization slumped 72.62% in 2025 and surged 174.79% in 2026.
• Over 5 years, Market Capitalization stood at $221.5 million in 2022, then grew by 0.38% to $222.4 million in 2023, then slumped by 53.52% to $103.4 million in 2024, then rose by 23.66% to $127.8 million in 2025, then soared by 51.06% to $193.1 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $193.1 million in Q2 2026, $170.5 million in Q1 2026, and $127.8 million in Q4 2025.